Evaluation of potency of measles vaccine used in Iran: comparison of WHO and NIBSC method in cell culture

Shohreh Tavajohi; Hossein Rastegar; Seyed Nasser Ostad; Seyed Mehdi Rezayat; Mohammad  Hossein Ghahremani

doi:10.22037/ijpr.2010.631

IJ Pharmaceutical Research

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Contact Us Support

APC

Authors Guide Submit Manuscript

https://doi.org/10.22037/ijpr.2010.631

Evaluation of potency of measles vaccine used in Iran: comparison of WHO and NIBSC method in cell culture

Author(s):

Shohreh Tavajohi^{1, 2},

Hossein Rastegar¹,

Seyed Nasser Ostad³,

Seyed Mehdi Rezayat²,

Mohammad Hossein Ghahremani^3,*

1Food and Drug Control Lab, Ministry of Health and Medical Education, Tehran, Iran

2Department of Pharmacology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

3Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

IJ Pharmaceutical Research:Vol. 4, issue 3; 155-160

Published online:Nov 20, 2010

Article type:Research Article

Received:May 20, 2004

Accepted:Sep 20, 2005

How to Cite:Shohreh TavajohiHossein RastegarSeyed Nasser OstadSeyed Mehdi RezayatMohammad Hossein GhahremaniEvaluation of potency of measles vaccine used in Iran: comparison of WHO and NIBSC method in cell culture.Iran J Pharm Res.4(3):e128239.https://doi.org/10.22037/ijpr.2010.631.

Abstract

Measles has been a major cause of illness and death in children and vaccination against the disease is part of the WHO global immunization program. A suitable vaccine should create maximum immune response against the pathogen and must be safe for the user. Thus, after production, vaccines must be analyzed and controlled by the producer and confirm by relevant governmental organizations. The Food and Drug Control Lab (FDCL), Ministry of Health, is the secondary control center on potency of vaccines in Iran. In this study, we have set up the WHO and NIBSC methods in FDCL and compare these methods on determining the potency of measles vaccine.

Measles vaccines were obtained from Razi Institute Iran. Nine dilutions of vaccine (10^-1 to 10^-5) in 0.5 log interval were mixed with Vero cell suspension and seeded. In WHO method, the cells were incubated at 36°C for 10 days, during which the cells were checked for cytopatic changes everyday. To set up the assay, we tested the vaccine dilution with four different cell suspensions (2×10⁵-5×10⁴/well) and four different concentration of serum (2.5-10%). Based on our results, in the assays, 5% serum and 1×10⁵ cells were used. The potency assay was performed with six different vaccines produced in one batch and the mean potency for Measles was 10^{4.32 ± 0.24}CCID₅₀/vial for a ten-dose vial. In NIBSC method following seeding of Vero cells, the medium was removed after 3 hours and overlay was added. Then the plates were incubated at 35°C for 10 days. After incubation period, the overlay was removed, the plaques were stained with methyl violet and counted. This assay was repeated three times and the mean of the results was 5.83 ± 0.03 log₁₀ PFU/dose.

In this study, we have set up the WHO and NIBSC methods and results indicated that the potency of the vaccine is in acceptable range in either method. Furthermore, the WHO method is simple and less time consuming compared to NIBSC which is complicated and requires more effort to produce reproducible results.

Keywords

comments

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Shohreh Tavajohi:[PubMed][Scholar]
Hossein Rastegar:[PubMed][Scholar]
Seyed Nasser Ostad:[PubMed][Scholar]
Seyed Mehdi Rezayat:[PubMed][Scholar]
Mohammad Hossein Ghahremani:[PubMed][Scholar]